PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. aribas@mednet.ucla.edu.\', \'Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, Atlanta, Georgia.\', \'Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.\', \'Department of Medicine and Perlmutter Cancer Center, New York University, New York, New York.\', \'AACR Hematologic Malignancies Task Force, Philadelphia, Pennsylvania.\', \'Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.\', \'Department of Medicine, Stanford University, Palo Alto, California.\', \'The Leukemia & Lymphoma Society, Rye Brook, New York.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1158/2643-3230.BCD-21-0166
?:doi
?:hasPublicationType
?:journal
  • Blood cancer discovery
is ?:pmid of
?:pmid
?:pmid
  • 34778796
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34778796>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34778796>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all